Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity.
J Immunother Cancer. 2020 Mar;8(1):e000326. doi: 10.1136/jitc-2019-000326.
J Immunother Cancer. 2020.
PMID: 32188703
Free PMC article.